Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2018 Oct 1;79 Suppl 1(Suppl 1):S30-S36.
doi: 10.1097/QAI.0000000000001818.

Exceptional Risk: Healthy Volunteers' Perceptions of HIV/AIDS Clinical Trials

Marci D Cottingham  1 , Julianne M Kalbaugh  2 , Teresa Swezey  3 , Jill A Fisher  2
Affiliations
Clinical Trial

Exceptional Risk: Healthy Volunteers' Perceptions of HIV/AIDS Clinical Trials

Marci D Cottingham et al. J Acquir Immune Defic Syndr. .

Abstract

As with all early-stage testing of investigational drugs, clinical trials targeting HIV/AIDS can pose unknown risks to research subjects. Unlike sick participants seeking a therapeutic benefit, the motivations and barriers for healthy volunteers are more complex and understudied. Drawing on interviews and clinical trial data from 178 healthy volunteers, we examine how they perceive HIV/AIDS studies in the early stages of testing. A subset of healthy volunteers see phase I HIV/AIDS studies as particularly risky for reasons ranging from fear of catching the disease or having long-lasting and uncomfortable side effects to inexplicable fears that they cannot even articulate. Some participants have had past negative experiences in such trials that inform these views, but others cite information from staff and other participants as influential. Healthy volunteers' general fears concerning AIDS also shape their views of participating in phase I HIV/AIDS clinical trials.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

References

    1. Fisher JA. Medical Research for Hire: The Political Economy of Pharmaceutical Clinical Trials. New Brunswick, NJ: Rutgers University Press; 2009.
    1. Mirowski P. Science-Mart: Privatizing American Science. Cambridge, MA: Harvard University Press; 2011.
    1. Petryna A. When Experiments Travel: Clinical Trials and the Global Search for Human Subjects. Princeton, NJ: Princeton University Press; 2009.
    1. Rajan KS. Experimental Values: Indian Clinical Trials and Surplus Health. NewLeftRev. 2007;45:67–88.
    1. Shah S. The Body Hunters: How the Drug Industry Tests its Products on the World’s Poorest Patients. New York, NY: The New Press; 2006.

Publication types

Substances